Three traditional Dow components—CVS Health, Goldman Sachs, and Caterpillar—have significantly outperformed broader market benchmarks over the past year, driven by their strong market positions, hard-asset moats, and AI integration. CVS Health rose 52.1% with improved healthcare benefits and AI-powered prior authorizations. Goldman Sachs gained 71.4%, benefiting from record advisory fees and AI productivity initiatives. Caterpillar led with a 159.1% increase, fueled by demand in power generation and infrastructure, supported by AI-driven data center investments. Despite risks like regulatory pressures and cyclical volatility, these stocks showcase how old-economy firms leverage AI to sustain growth and market leadership.
CVS Health has made the updated 2026-2027 flu vaccines available at CVS Pharmacy and MinuteClinic locations nationwide. Over 60% of consumers are likely to get a flu shot this season, according to a CVS survey, highlighting strong demand. The CDC rec...
In 2026, both CVS and Intel showed strong turnaround results but faced stock sell-offs for different reasons. Intel's decline stems from doubts about its 18A manufacturing roadmap and competitive pressure, while CVS's drop relates to a cautious 2027 ...
Health insurance stocks are rising sharply following strong second-quarter earnings and improved cost management. UnitedHealth Group reported over $5 billion in net income with a lower medical care ratio, signaling better control of medical expenses....
CVS Health's integrated healthcare model across insurance, pharmacy, and clinical care supports its long-term margin recovery and revenue growth. The recent stock selloff has lowered its price-to-earnings ratio to 11.78, making it an attractive buy w...
